For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20231113:nRSM1548Ta&default-theme=true
RNS Number : 1548T Agronomics Limited 13 November 2023
13 November 2023
Agronomics Limited
("Agronomics" or the "Company")
'Good Dog Food' becomes 'Meatly' in preparation for UK product launch
Agronomics (ANIC:LSE), the leading listed company focused on the field of
cellular agriculture, is pleased to announce that portfolio company Good Dog
Food Ltd has rebranded and will now be trading as 'Meatly' in preparation for
its upcoming UK product launch.
Since its launch in 2022, Meatly's team of leading scientists has been working
to produce ethical and sustainable cultivated meat for pets without
compromising on essential nutritional benefits. The team makes real meat,
without animals.
Agronomics has invested £1.2 million into Meatly since inception, which is
currently carried at £4.95 million. This position accounts for approximately
2.9% of Agronomics last published Net Asset Value (30/09/23)
(https://polaris.brighterir.com/public/agronomics/news/rns/story/rdlm2px) ,
including post-balance sheet adjustments. Agronomics has an equity ownership
of 40.7% on a fully diluted basis.
As part of the rebrand, Meatly has launched a new consumer-facing website,
www.meatly.pet (http://www.meatly.pet)
CEO Owen Ensor, said: "We're thrilled to announce our rebrand to Meatly, in
what marks an exciting new chapter for us as a team and brand. We chose the
name 'Meatly' because we wanted to celebrate the fact that that is real meat,
made the new way. Our hope is that Meatly will quickly become a household
name, loved by pets and pet parents alike, and recognised as the choice for
healthy, sustainable, delicious pet food."
"Our pets love meat, but old-fashioned meat, produced through factory
farming, requires a huge amount of land, water and antibiotics and is a key
cause of environmental degradation. We need cultivated meat now more than
ever. Pet food is the natural starting point, given consumers' excitement.
We're thrilled to be at the heart of the future of meat production in the UK."
For more information on the status of Meatly production and product
availability, please visit the Meatly website: www.meatly.pet
(http://www.meatly.pet)
About Meatly
Meatly (previously known as Good Dog Food) was founded in 2022 by CEO Owen
Ensor and CSO Helder Cruz with backing from investor Agronomics. The company
works to produce ethical and sustainable cultivated meat products for pets
without compromising on essential nutritional benefits.
About Agronomics
Agronomics (https://agronomics.im/) is the leading listed venture capital firm
with a focus on cellular agriculture. The Company has established a portfolio
of over 20 companies at the Pre-Seed to Series C stage in this rapidly
advancing sector. It seeks to secure minority stakes in companies owning
technologies with defensible intellectual property that offer new ways of
producing food and materials with a focus on products historically derived
from animals. These technologies are driving a major disruption in
agriculture, offering solutions to improve sustainability, as well as
addressing human health, animal welfare and environmental damage. This
disruption will decouple supply chains from the environment and animals, as
well as being fundamental to feeding the world's expanding population.
About Cellular Agriculture
Cellular Agriculture is the production of agriculture products directly from
cells, as opposed to raising an animal for slaughter or growing crops. This
encompasses cell culture to produce cultivated meat and materials, and
fermentation processes that harness a combination of molecular biology,
synthetic biology, tissue engineering and biotechnology to massively simplify
production methods in a sustainable manner.
Over the coming decades, the source of the world's food supply traditionally
derived from conventional agriculture is going to change dramatically. We have
already witnessed the first wave of this shift with the consumer adoption of
plant-based alternative proteins but today, we are on the cusp of an even
bigger wave of change. This is being facilitated by advances in cellular
agriculture. This change is necessary, given scientists' claims that if we
maintain existing animal protein consumption patterns, then we will not meet
the Paris Agreement's goal of limiting warming to 1.5℃.
AT Kearney, a global consultancy firm, projects that cultivated meat's market
share will reach 35% by 2040. This combined with the Good Food Institute's
estimate that a US $1.8 trillion investment will be required in order to
produce just 10% of the world's protein using this technology, means that we
are on the cusp of a multi-decade flow of capital to build out manufacturing
facilities. Funding in the field of cellular agriculture is accelerating,
however, still, less than US$ 5 billion has been invested worldwide since the
industry's inception in 2016.
For further information please contact:
Agronomics Beaumont Canaccord Genuity Limited Cavendish Peterhouse Capital SEC Newgate
Limited Cornish Limited Securities Plc Limited
The Company Nomad Joint Broker Joint Broker Joint Broker Public Relations
Richard Reed Roland Cornish Andrew Potts Giles Balleny Lucy Williams Bob Huxford
Denham Eke James Biddle Harry Rees Michael Johnson Charles Goodfellow George Esmond
Alex Aylen (Head of Equities) Anthony Hughes
Alice Cho
+44 (0) 1624 639396 +44 (0) 207 628 3396 +44 (0) 207 523 8000 +44 (0) 207 397 8900 +44 (0) 207 469 0936 agronomics@secnewgate.co.uk
info@agronomics.im
This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END NRADZMMMLGKGFZM